Showing 81 - 100 results of 22,389 for search '(((( c largest decrease ) OR ( ((i large) OR (b large)) decrease ))) OR ( c cases increased ))*', query time: 1.12s Refine Results
  1. 81

    The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. by Simon K. Schnyder (16632244)

    Published 2023
    “…Brighter colours indicate higher 〈<i>s</i>(<i>t</i><sub><i>v</i></sub>)〉. Note the nonlinear increase of <i>n</i> on the y-axis. C) Relatedly, we show the peak of infections max<sub><i>t</i></sub>(<i>i</i>(<i>t</i>)) as a heat map as function of the expected vaccination time 〈<i>t</i><sub><i>v</i></sub>〉 for the same range of vaccine arrival distributions <i>p</i><sub><i>n</i></sub> as in B). …”
  2. 82

    Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”
  3. 83

    Image_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  4. 84

    Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”
  5. 85

    Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

    Published 2023
    “…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91

    Decreased CNPase levels in the SG/RC in <i>Large</i><sup><i>myd/myd</i></sup> <i>mice</i>. by Shigefumi Morioka (8893511)

    Published 2020
    “…<p>Lysates were obtained from the spiral ganglion (SG)/Rosenthal’s canal (RC) of the P5-7 control and <i>Large</i><sup><i>myd/myd</i></sup> mice. CNPase immunoblotting showed decreased levels of CNPase in the <i>Large</i><sup><i>myd/myd</i></sup> mice. …”
  12. 92
  13. 93
  14. 94

    Table1_A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China.docx by Chunli Yang (2087218)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma subtype worldwide and occurs frequently in the elderly population. …”
  15. 95
  16. 96

    Temporal trends in large carnivore attacks on humans in different regions of the world. by Giulia Bombieri (8613945)

    Published 2023
    “…In countries with (<b>D</b>) large forest coverage, the number of attacks in the last several years has decreased. …”
  17. 97

    DataSheet_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.xlsx by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  18. 98

    DataSheet_1_Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.xlsx by Haoguang Li (2829245)

    Published 2022
    “…<p>The relationship between rheumatoid arthritis (RA) and diffuse large B-cell lymphoma (DLBCL) is well characterized, but the molecular mechanisms underlying this association have not been clearly investigated. …”
  19. 99

    Table1_Multi-Scale Modeling Recapitulates the Effect of Genetic Alterations Associated With Diffuse Large B-Cell Lymphoma in the Germinal Center Dynamics.docx by Elena Merino Tejero (10102450)

    Published 2022
    “…In this study, we used an existing MSM of PC differentiation in the GC to simulate eight different models with several candidate genetic alterations of the BCL6-IRF4-BLIMP1 regulatory network that lead to transcription factor deregulation and could explain the onset of diffuse large B-cell lymphoma and recapitulate the GC dynamics observed in such conditions. …”
  20. 100

    Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx by Lili Zhou (265076)

    Published 2025
    “…However, the specific role and underlying molecular mechanisms of cholesterol metabolism alterations in diffuse large B-cell lymphoma (DLBCL) remain poorly understood.…”